Tsutomu Takeuchi

TAKEUCHI_PHOTO
TAKEUCHI_PHOTO

Dr. Tsutomu Takeuchi is Professor of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University in Tokyo, Japan. He is also a visiting professor of Saitama Medical University, and at Tokyo Dental University.

After completing his medical education at Keio University School of Medicine, Dr. Takeuchi was awarded clinical and research fellowships in the Division of Rheumatology and Clinical Immunology at Keio University, where he received a research award for bone and joint disease. Subsequently, he was a research fellow at Dana-Farber Cancer Institute in Boston, Massachusetts, where his research centered on human immunology.

The recipient of numerous awards for his research into intractable diseases, including the 36th Japan College of Rheumatology Award at 1993, the Uehara memorial award for life science at 1998, the Naitoh Foundation award at 1999, and Waksman Foundation award at 2004. Dr. Takeuchi is a productive author and researcher. He has published articles widely in peer-reviewed journals such as Arthritis & Rheumatism, Ann Rheum Dis, J Immunology, Rheumatology, J Rheumatology, and J Clin Invest. He serves or served as an editorial board member of Rheumatology, Clinical Rheumatology, Clinical Immunology, and Modern Rheumatology. He is a chief investigator of the study group for establishing a tailor-made therapeutic algorithm for Rheumatoid Arthritis, sponsored by Ministry of Health, Labor, and Welfare, Japan. He is a principal investigator/investigator of several clinical trials against Rheumatoid Arthritis carried out in Japan, including Leflunomide, tacrolimus, Infliximab, etanercept, tocilizmab, abatacept, golimumab, certolizumab and denosumab. Also, He is a principal investigator/investigator for sifalimumab and abatacept trial in SLE. Dr. Takeuchi serves as a member of governing boards of the Japanese College of Rheumatology (JCR), and a chairman of guidelines for biological agents in rheumatic diseases of JCR. He is also a member of the governing boards of the Japanese Society for Clinical Immunology, the Japanese Society for Clinical Rheumatology, and the Japanese Society for Inflammation and Regeneration.